September 18, 2026

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: Navigating Its Stable Price and Future Prospects

KalVista Pharmaceuticals, Inc. (KALV), listed on the U.S. market, stands as a notable entity in the biotechnology sector. With a market capitalization of $1.44 billion, the company specializes in developing..

REGENXBIO Inc. (RGNX) Stock Analysis: Exploring a Potential 188.83% Upside in Biotech Innovation

For investors with an eye on biotech, REGENXBIO Inc. (NASDAQ: RGNX) offers a captivating opportunity driven by its innovative gene therapy solutions and significant potential upside. With a current stock..

CeriBell, Inc. (CBLL) Stock Analysis: Exploring the 12% Potential Upside in the Innovative Medical Device Sector

CeriBell, Inc. (CBLL), a key player in the healthcare sector, specifically within the medical devices industry, has captured the attention of investors with its innovative approach to acute care. The..

Talkspace, Inc. (TALK) Stock Analysis: Exploring a 21.43% Potential Upside in the Digital Healthcare Sector

In an era where mental health awareness is gaining prominence, Talkspace, Inc. (NASDAQ: TALK) stands at the forefront of digital behavioral healthcare. With its innovative approach to connecting patients with..

Nutex Health Inc. (NUTX) Stock Analysis: Investor Optimism with a 32% Upside Potential

For investors in the healthcare sector, Nutex Health Inc. (NUTX) presents a compelling opportunity. This Houston-based company, with a market capitalization of $1.47 billion, is a key player in the..

Avanos Medical, Inc. (AVNS) Stock Analysis: Revenue Growth and Challenges in Focus for Healthcare Investors

For investors with an eye on the healthcare sector, Avanos Medical, Inc. (NYSE: AVNS) stands out as a significant player in the medical devices industry. With a market capitalization of..

STAAR Surgical Company (STAA) Stock Analysis: Exploring a 31% Potential Upside in the Healthcare Sector

As an intriguing player in the healthcare sector, STAAR Surgical Company (NASDAQ: STAA) is attracting attention with its innovative solutions and promising growth potential. Specializing in medical instruments and supplies,..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Unveiling a 97.71% Upside Potential in Biotech Innovation

Tyra Biosciences, Inc. (TYRA), a clinical-stage biotechnology company, is captivating investors with its ambitious approach to precision medicine, particularly in targeting fibroblast growth factor receptor (FGFR) biology. Headquartered in Carlsbad,..

Geron Corporation (GERN) Stock Analysis: Exploring a 221.97% Potential Upside in the Biotech Sector

Geron Corporation (NASDAQ: GERN), a biopharmaceutical company headquartered in Foster City, California, stands at the forefront of oncology therapeutics development. With a market capitalization of $848.06 million, Geron is making..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: Explosive 57.62% Upside Potential Fuels Investor Interest

ArriVent BioPharma, Inc. (NASDAQ: AVBP) is capturing the attention of the investment community with its robust potential for growth and notable developments in the biotechnology sector. As a clinical-stage biopharmaceutical..

Community Health Systems, Inc. (CYH) Stock Analysis: Potential 8.86% Upside Amidst Challenging Metrics

Community Health Systems, Inc. (NYSE: CYH) operates at the heart of America’s healthcare delivery, running general acute care hospitals and a variety of associated healthcare facilities. Based in Franklin, Tennessee,..

Xencor, Inc. (XNCR) Stock Analysis: Biotech Innovator with a 25% Upside Potential

Xencor, Inc. (XNCR), a clinical-stage biopharmaceutical company, is gaining traction in the healthcare sector with its cutting-edge antibody engineering technology. Headquartered in Pasadena, California, Xencor is at the forefront of..

Evolus, Inc. (EOLS) Stock Analysis: Exploring an 87% Potential Upside in the Aesthetic Beauty Market

Evolus, Inc. (NASDAQ: EOLS) has been making waves in the aesthetic beauty industry with its innovative offerings, including the popular Jeuveau and Evolysse product lines. As a specialty drug manufacturer..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Potential Upside Amid Strong Buy Ratings

OrthoPediatrics Corp. (NASDAQ: KIDS) stands out in the healthcare sector with its focus on pediatric medical devices, a niche yet crucial segment within the broader medical devices industry. With a..

iRadimed Corporation (IRMD) Stock Analysis: Exploring a 42% Upside Potential for Investors

iRadimed Corporation (NASDAQ: IRMD), a prominent player in the healthcare sector, specializes in manufacturing and distributing MRI-compatible medical devices. With a market capitalization of $1.06 billion, iRadimed stands out in..

Replimune Group, Inc. (REPL) Stock Analysis: A Potential 51.52% Upside in Biotech Innovations

Replimune Group, Inc. (NASDAQ: REPL) stands out in the biotechnology sector with its innovative approach to cancer treatment through oncolytic immunotherapies. With a market capitalization of $1.21 billion, this clinical-stage..

Sionna Therapeutics, Inc. (SION) Stock Analysis: Unpacking a 192% Potential Upside in the Biotech Space

Sionna Therapeutics, Inc. (NASDAQ: SION), a clinical-stage biopharmaceutical company headquartered in Waltham, Massachusetts, has captured investor attention with its promising pipeline of treatments for cystic fibrosis. The biotech sector is..

Akso Health Group (AHG) Stock Analysis: Navigating Challenges in the Medical Distribution Sector

As individual investors scour the healthcare sector for promising opportunities, Akso Health Group (AHG) emerges as a complex case. Based in Qingdao, China, this company operates within the medical distribution..

Savara, Inc. (SVRA) Stock Analysis: Exploring a Potential 101.80% Upside in Biotech Investment

Savara, Inc. (NASDAQ: SVRA) is capturing investor attention with its promising potential upside, highlighted by an impressive 101.80% gain according to analyst ratings. As a clinical-stage biopharmaceutical company, Savara focuses..

Beta Bionics, Inc. (BBNX) Stock Analysis: Navigating Growth Prospects and a 37.8% Revenue Surge in the Medical Device Arena

Beta Bionics, Inc. (NASDAQ: BBNX) is making waves in the healthcare sector with its innovative approach to diabetes care. As a commercial-stage medical device company, Beta Bionics is dedicated to..

Search

Funds

September 18, 2026

Search

Funds

September 18, 2026

FTSE 100

Funds